ID   G3P1_STAAW              Reviewed;         336 AA.
AC   P0A037; Q9Z5C5;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   07-APR-2021, entry version 100.
DE   RecName: Full=Glyceraldehyde-3-phosphate dehydrogenase 1 {ECO:0000250|UniProtKB:Q6GIL8};
DE            Short=GAPDH 1 {ECO:0000250|UniProtKB:Q6GIL8};
DE            EC=1.2.1.12 {ECO:0000250|UniProtKB:Q6GIL8};
DE   AltName: Full=NAD-dependent glyceraldehyde-3-phosphate dehydrogenase {ECO:0000250|UniProtKB:Q6GIL8};
GN   Name=gapA1; Synonyms=gap, gapA; OrderedLocusNames=MW0734;
OS   Staphylococcus aureus (strain MW2).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=196620;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MW2;
RX   PubMed=12044378; DOI=10.1016/s0140-6736(02)08713-5;
RA   Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y.,
RA   Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., Hiramatsu K.;
RT   "Genome and virulence determinants of high virulence community-acquired
RT   MRSA.";
RL   Lancet 359:1819-1827(2002).
CC   -!- FUNCTION: Catalyzes the oxidative phosphorylation of glyceraldehyde 3-
CC       phosphate (G3P) to 1,3-bisphosphoglycerate (BPG) using the cofactor
CC       NAD. The first reaction step involves the formation of a hemiacetal
CC       intermediate between G3P and a cysteine residue, and this hemiacetal
CC       intermediate is then oxidized to a thioester, with concomitant
CC       reduction of NAD to NADH. The reduced NADH is then exchanged with the
CC       second NAD, and the thioester is attacked by a nucleophilic inorganic
CC       phosphate to produce BPG. {ECO:0000250|UniProtKB:Q6GIL8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glyceraldehyde 3-phosphate + NAD(+) + phosphate = (2R)-3-
CC         phospho-glyceroyl phosphate + H(+) + NADH; Xref=Rhea:RHEA:10300,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57604, ChEBI:CHEBI:57945, ChEBI:CHEBI:59776; EC=1.2.1.12;
CC         Evidence={ECO:0000250|UniProtKB:Q6GIL8};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 1/5. {ECO:0000305}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:Q6GIL8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the glyceraldehyde-3-phosphate dehydrogenase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000033; BAB94599.1; -; Genomic_DNA.
DR   RefSeq; WP_000279414.1; NC_003923.1.
DR   SMR; P0A037; -.
DR   EnsemblBacteria; BAB94599; BAB94599; BAB94599.
DR   GeneID; 59699413; -.
DR   KEGG; sam:MW0734; -.
DR   HOGENOM; CLU_030140_0_0_9; -.
DR   OMA; NCVAPMA; -.
DR   BioCyc; SAUR196620:G1G3G-830-MONOMER; -.
DR   UniPathway; UPA00109; UER00184.
DR   Proteomes; UP000000418; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004365; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; ISS:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR020831; GlycerAld/Erythrose_P_DH.
DR   InterPro; IPR020830; GlycerAld_3-P_DH_AS.
DR   InterPro; IPR020829; GlycerAld_3-P_DH_cat.
DR   InterPro; IPR020828; GlycerAld_3-P_DH_NAD(P)-bd.
DR   InterPro; IPR006424; Glyceraldehyde-3-P_DH_1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF02800; Gp_dh_C; 1.
DR   Pfam; PF00044; Gp_dh_N; 1.
DR   PIRSF; PIRSF000149; GAP_DH; 1.
DR   PRINTS; PR00078; G3PDHDRGNASE.
DR   SMART; SM00846; Gp_dh_N; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01534; GAPDH-I; 1.
DR   PROSITE; PS00071; GAPDH; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Glycolysis; NAD; Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..336
FT                   /note="Glyceraldehyde-3-phosphate dehydrogenase 1"
FT                   /id="PRO_0000145687"
FT   NP_BIND         12..13
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   REGION          150..152
FT                   /note="Glyceraldehyde 3-phosphate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   REGION          211..212
FT                   /note="Glyceraldehyde 3-phosphate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   ACT_SITE        151
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   BINDING         34
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   BINDING         120
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   BINDING         181
FT                   /note="Glyceraldehyde 3-phosphate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   BINDING         198
FT                   /note="Glyceraldehyde 3-phosphate"
FT                   /evidence="ECO:0000250|UniProtKB:P00362"
FT   BINDING         234
FT                   /note="Glyceraldehyde 3-phosphate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   BINDING         316
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
FT   SITE            178
FT                   /note="Activates thiol group during catalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GIL8"
SQ   SEQUENCE   336 AA;  36281 MW;  37A6CEA9376779E5 CRC64;
     MAVKVAINGF GRIGRLAFRR IQEVEGLEVV AVNDLTDDDM LAHLLKYDTM QGRFTGEVEV
     VDGGFRVNGK EVKSFSEPDA SKLPWKDLNI DVVLECTGFY TDKDKAQAHI EAGAKKVLIS
     APATGDLKTI VFNTNHQELD GSETVVSGAS CTTNSLAPVA KVLNDDFGLV EGLMTTIHAY
     TGDQNTQDAP HRKGDKRRAR AAAENIIPNS TGAAKAIGKV IPEIDGKLDG GAQRVPVATG
     SLTELTVVLE KQDVTVEQVN EAMKNASNES FGYTEDEIVS SDVVGMTYGS LFDATQTRVM
     SVGDRQLVKV AAWYDNEMSY TAQLVRTLAY LAELSK
//
